BlackRock Advisors’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

BlackRock Advisors’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$7K	Hold	1,331	–	–	﹤0.01%	3610
2016 Q3	$12K	Hold	1,331	–	–	﹤0.01%	3554
2016 Q2	$13K	Hold	1,331	–	–	﹤0.01%	3542
2016 Q1	$12K	Hold	1,331	–	–	﹤0.01%	3554
2015 Q4	$17K	Hold	1,331	–	–	﹤0.01%	3537
2015 Q3	$16K	Buy	1,331 +860	+183%	+$12.4K	﹤0.01%	3568
2015 Q2	$8K	Buy	+471	New	+$8.48K	﹤0.01%	3640
2014 Q3	–	Sell	-2,111	Closed	-$39K	–	3742
2014 Q2	$39K	Sell	2,111 -8,364	-80%	-$109K	﹤0.01%	3299
2014 Q1	$157K	Sell	10,475 -11,820	-53%	-$212K	﹤0.01%	2795
2013 Q4	$408K	Sell	22,295 -23,150	-51%	-$464K	﹤0.01%	2180
2013 Q3	$936K	Sell	45,445 -70,653	-61%	-$1.62M	﹤0.01%	1468
2013 Q2	$2.9M	Buy	+116,098	New	+$4.96M	﹤0.01%	1082

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

DVC

Deer VI & Co Larchmont, New York $2.23M AUM 9.32% 1-Year Est. Return

BlackRock Advisors's AVEO Position: Q4 2016 in Review

BlackRock Advisors held its AVEO Pharmaceuticals, Inc. (AVEO) position steady in Q4 2016 at 1,331 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #3610.

BlackRock Advisors first reported a position in AVEO in Q2 2013 and has held it in 12 quarters since. The position peaked at $2.9M in Q2 2013. 44 funds tracked by Wall St. Rank hold AVEO as of Q4 2016.

BlackRock Advisors held 1,331 shares of AVEO Pharmaceuticals, Inc. worth $7K as of Q4 2016.
BlackRock Advisors left its AVEO Pharmaceuticals, Inc. share count unchanged in Q4 2016.
AVEO Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3610 holding.
BlackRock Advisors first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and has held it in 12 quarters since.
BlackRock Advisors's AVEO Pharmaceuticals, Inc. position peaked at $2.9M in Q2 2013.
44 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.